Home-based HPV self-sampling assisted by a cloud-based electronic data system: Lessons learnt from a pilot community cervical cancer screening campaign in rural Ethiopia
Felix Jede , Theresa Brandt , Molla Gedefaw , Solomon Berhe Wubneh , Tamrat Abebe , Brhanu Teka , Kassahun Alemu , Binyam Tilahun , Temesgen Azemeraw , Abebaw Gebeyehu , Dietmar Schmidt , Aleksandra Pesic , Andreas M. Kaufmann , Bewketu Abebe , Zelalem Ayichew , Michael Byczkowski , Timoté Vaucher , Heike Sartor , Gashaw Andargie , Till Bärnighausen , Hermann Bussmann
{"title":"Home-based HPV self-sampling assisted by a cloud-based electronic data system: Lessons learnt from a pilot community cervical cancer screening campaign in rural Ethiopia","authors":"Felix Jede , Theresa Brandt , Molla Gedefaw , Solomon Berhe Wubneh , Tamrat Abebe , Brhanu Teka , Kassahun Alemu , Binyam Tilahun , Temesgen Azemeraw , Abebaw Gebeyehu , Dietmar Schmidt , Aleksandra Pesic , Andreas M. Kaufmann , Bewketu Abebe , Zelalem Ayichew , Michael Byczkowski , Timoté Vaucher , Heike Sartor , Gashaw Andargie , Till Bärnighausen , Hermann Bussmann","doi":"10.1016/j.pvr.2020.100198","DOIUrl":null,"url":null,"abstract":"<div><p>Primary HPV testing and triage of HPV-positive women is an effective cervical cancer screening strategy. Such a multi-visit screening algorithm is also promising for community-based screening in resource-poor communities, provided a robust tracking system is in place.</p><p>A cervical cancer screening campaign was conducted in a rural community in Ethiopia. All women aged 25–65 years were offered genital self-sampling using the Evalyn Brush®. Samples were HPV-DNA-tested at a central laboratory. Key indicators were captured on tablet computers and linked by a cloud-based information system. HPV-positive women were examined at the local clinic using portable colposcopy, p16/Ki-67 dual stain cytology and biopsy examination. CIN2+ women were referred for LEEP to the referral hospital.</p><p>Of 749 enumerated age-eligible women 634 (85%, (95% CI 82–88)) consented to screening, 429 samples were adequate for HPV testing, giving a total testing coverage of 57% (95% CI 53–62). The hrHPV prevalence was 14% (95% CI 5–22), 72% (95% CI 60–84) attended the clinic for a triage examination. Home-based HPV-DNA self-sampling and clinic-based triage assisted by cloud-based information technology is feasible in rural Ethiopia. Key components of such strategy are broad community awareness, high competency of community workers, and establishment of an adequate self-sampling and HPV-DNA testing platform.</p></div>","PeriodicalId":46835,"journal":{"name":"Papillomavirus Research","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2020-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.pvr.2020.100198","citationCount":"13","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Papillomavirus Research","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405852120300057","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 13
Abstract
Primary HPV testing and triage of HPV-positive women is an effective cervical cancer screening strategy. Such a multi-visit screening algorithm is also promising for community-based screening in resource-poor communities, provided a robust tracking system is in place.
A cervical cancer screening campaign was conducted in a rural community in Ethiopia. All women aged 25–65 years were offered genital self-sampling using the Evalyn Brush®. Samples were HPV-DNA-tested at a central laboratory. Key indicators were captured on tablet computers and linked by a cloud-based information system. HPV-positive women were examined at the local clinic using portable colposcopy, p16/Ki-67 dual stain cytology and biopsy examination. CIN2+ women were referred for LEEP to the referral hospital.
Of 749 enumerated age-eligible women 634 (85%, (95% CI 82–88)) consented to screening, 429 samples were adequate for HPV testing, giving a total testing coverage of 57% (95% CI 53–62). The hrHPV prevalence was 14% (95% CI 5–22), 72% (95% CI 60–84) attended the clinic for a triage examination. Home-based HPV-DNA self-sampling and clinic-based triage assisted by cloud-based information technology is feasible in rural Ethiopia. Key components of such strategy are broad community awareness, high competency of community workers, and establishment of an adequate self-sampling and HPV-DNA testing platform.
对HPV阳性妇女进行初步HPV检测和分诊是一种有效的宫颈癌筛查策略。如果有一个健全的跟踪系统,这种多次访问筛查算法也有望用于资源贫乏社区的社区筛查。在埃塞俄比亚的一个农村社区开展了宫颈癌筛查运动。所有25-65岁的女性都使用Evalyn刷子进行生殖器自采样。在一个中心实验室对样本进行了hpv dna检测。关键指标被记录在平板电脑上,并通过基于云的信息系统进行链接。hpv阳性妇女在当地诊所进行便携式阴道镜检查、p16/Ki-67双染色细胞学检查和活检检查。CIN2+的妇女因LEEP被转介到转诊医院。在749名经点算的符合年龄的妇女中,634名(85%,95% CI 82-88)同意接受筛查,429份样本足以进行HPV检测,总检测覆盖率为57% (95% CI 53-62)。hrHPV患病率为14% (95% CI 5-22), 72% (95% CI 60-84)到诊所接受分诊检查。在埃塞俄比亚农村,基于家庭的HPV-DNA自采样和基于云的信息技术辅助的基于诊所的分诊是可行的。这一战略的关键组成部分是广泛的社区意识、社区工作人员的高能力以及建立适当的自我采样和HPV-DNA检测平台。
期刊介绍:
The official Journal of the International Papillomavirus Society Papillomavirus Research (PVR), the Journal of HPV and other Small DNA Tumor Viruses publishes innovative papers related to all aspects of papillomaviruses and other small DNA tumor viruses. The official journal of the International Papillomavirus Society, PVR is an open access publication that aims to bring together virologists, immunologists, epidemiologists and clinicians working in the booming field of HPV and animal papillomaviruses, polyomaviruses and other small DNA tumor viruses and their associated diseases, in order to foster and facilitate interdisciplinary communication. The journal welcomes original research articles, reviews, short communications, opinion articles and regional update reports on papillomaviruses and other tumor viruses in the following sections: a. Biology of papillomaviruses and related viruses from life cycle to cancer b. Epidemiology etiology and natural history studies c. Natural and induced immunity including vaccine research d. Intervention studies and strategies including i. Clinical studies and trials ii. HPV treatments iii. HPV vaccination programs iv. Diagnostics and screening e. Infection and disease prevention, modeling studies f. Guidelines and public health recommendations g. HPV Studies in special populations Regional and local studies on these viruses.